Genes specifically downregulated in MDA-MB-231 cells were again enriched in pathways related to mitosis and chromosome segregation (Figure 6D), consistent with the results that cancer cells are more sensitive to CMPD1 treatment (Figure 2). This evidence concerns the gene SOX9 and cancer.